RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/31810373http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31810373http://www.w3.org/2000/01/rdf-schema#comment"Pancreatic cancer (PC) is a highly lethal human cancer. We previously found that Serine protease 3 (PRSS3), as an oncogene, is significantly upregulated in PC. In this study, we aimed to investigate the potential mechanism of PRSS3 dysregulation in PC. In this research, low miR-217 and high circ-ADAM9 expression were found in PC tissues and cell lines, which was closely associated with advanced clinical stage and lymph node metastasis. Patients with low miR-217 or high circ-ADAM9 expression had shorter survival time than those with high miR-217 or low circ-ADAM9 expression. Functionally, manipulation of miR-217 and circ-ADAM9 expression showed opposite effects on cell proliferation, migration and invasion. Stepwise mechanism studies indicated that circ-ADAM9 alleviated the inhibitory effect of miR-217 on PRSS3 by directly sponging miR-217 to increase the expression level of PRSS3, resulting in the activation of ERK/VEGF signalling pathway. In vivo, circ-ADAM9 silencing or miR-217 overexpression evidently retarded the growth of tumour, and the combination of them exhibited an additive inhibitory effect on tumourigenicity. Briefly, the ceRNA regulatory network of circ-ADAM9/miR-217/PRSS3 plays a pivotal role in PC progression by the regulation of ERK/VEGF signalling pathway."xsd:string
http://purl.uniprot.org/citations/31810373http://purl.org/dc/terms/identifier"doi:10.1080/21691401.2019.1671856"xsd:string
http://purl.uniprot.org/citations/31810373http://purl.uniprot.org/core/author"Zhang J."xsd:string
http://purl.uniprot.org/citations/31810373http://purl.uniprot.org/core/author"Sun M."xsd:string
http://purl.uniprot.org/citations/31810373http://purl.uniprot.org/core/author"Wang W."xsd:string
http://purl.uniprot.org/citations/31810373http://purl.uniprot.org/core/author"Zhao Z."xsd:string
http://purl.uniprot.org/citations/31810373http://purl.uniprot.org/core/author"Ye H."xsd:string
http://purl.uniprot.org/citations/31810373http://purl.uniprot.org/core/author"Jiang G."xsd:string
http://purl.uniprot.org/citations/31810373http://purl.uniprot.org/core/author"Xing C."xsd:string
http://purl.uniprot.org/citations/31810373http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/31810373http://purl.uniprot.org/core/name"Artif Cells Nanomed Biotechnol"xsd:string
http://purl.uniprot.org/citations/31810373http://purl.uniprot.org/core/pages"3920-3928"xsd:string
http://purl.uniprot.org/citations/31810373http://purl.uniprot.org/core/title"Circular RNA ADAM9 facilitates the malignant behaviours of pancreatic cancer by sponging miR-217 and upregulating PRSS3 expression."xsd:string
http://purl.uniprot.org/citations/31810373http://purl.uniprot.org/core/volume"47"xsd:string
http://purl.uniprot.org/citations/31810373http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/31810373
http://purl.uniprot.org/citations/31810373http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/31810373
http://purl.uniprot.org/uniprot/#_Q8N2U3-mappedCitation-31810373http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31810373
http://purl.uniprot.org/uniprot/#_P35030-mappedCitation-31810373http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31810373
http://purl.uniprot.org/uniprot/#_Q7Z5F4-mappedCitation-31810373http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31810373
http://purl.uniprot.org/uniprot/P35030http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/31810373
http://purl.uniprot.org/uniprot/Q7Z5F4http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/31810373
http://purl.uniprot.org/uniprot/Q8N2U3http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/31810373